Cystic fibrosis transmembrane conductance regulator MFYGIFLYLG EVTKAVQPLL LGRIIASYDP DNKEERSIAI YLGIGLCLLF IVRTLLLHPA IFGLHHIGMQ MRIAMFSLIY KKTLKLSSRV LDKISIGQLV SLLSNNLNKF DEGLALAHFV WIAPLQVALL MGLIWELLQA SAFCGLGFLI VLALFQAGLG RMMMKYRDQR AGKISERLVI TSEMIENIQS VKAYCWEEAM EKMIENLRQT ELKLTRKAAY VRYFNSSAFF FSGFFVVFLS VLPYALIKGI ILRKIFTTIS FCIVLRMAVT RQFPWAVQTW YDSLGAINKI QDFLQKQEYK TLEYNLTTTE VVMENVTAFW EETSLLMVIM GELEPSEGKI KHSGRISFCS QFSWIMPGTI KENIIFGVSY DEYRYRSVIK ACQLEEDISK FAEKDNIVLG EGGITLSGGQ RARISLARAV YKDADLYLLD SPFGYLDVLT EKEIFESCVC KLMANKTRIL VTSKMEHLKK ADKILILHEG SSYFYGTFSE LQNLQPDFSS KLMGCDSFDQ FSAERRNSIL TETLHRFSLE GDAPVSWTET KKQSFKQTGE FGEKRKNSIL NPINSIRKFS IVQKTPLQMN GIEEDSDEPL ERRLSLVPDS EQGEAILPRI SVISTGPTLQ ARRRQSVLNL MTHSVNQGQN IHRKTTASTR KVSLAPQANL TELDIYSRRL SQETGLEISE EINEEDLKEC FFDDMESIPA VTTWNTYLRY ITVHKSLIFV LIWCLVIFLA EVAASLVVLW LLGNTPLQDK GNSTHSRNNS YAVIITSTSS YYVFYIYVGV ADTLLAMGFF RGLPLVHTLI TVSKILHHKM LHSVLQAPMS TLNTLKAGGI LNRFSKDIAI LDDLLPLTIF DFIQLLLIVI GAIAVVAVLQ PYIFVATVPV IVAFIMLRAY FLQTSQQLKQ LESEGRSPIF THLVTSLKGL WTLRAFGRQP YFETLFHKAL NLHTANWFLY LSTLRWFQMR IEMIFVIFFI AVTFISILTT GEGEGRVGII LTLAMNIMST LQWAVNSSID VDSLMRSVSR VFKFIDMPTE GKPTKSTKPY KNGQLSKVMI IENSHVKKDD IWPSGGQMTV KDLTAKYTEG GNAILENISF SISPGQRVGL LGRTGSGKST LLSAFLRLLN TEGEIQIDGV SWDSITLQQW RKAFGVIPQK VFIFSGTFRK NLDPYEQWSD QEIWKVADEV GLRSVIEQFP GKLDFVLVDG GCVLSHGHKQ LMCLARSVLS KAKILLLDEP SAHLDPVTYQ IIRRTLKQAF ADCTVILCEH RIEAMLECQQ FLVIEENKVR QYDSIQKLLN ERSLFRQAIS PSDRVKLFPH RNSSKCKSKP QIAALKEETE EEVQDTRL